AIM ImmunoTech Announces that Recently Received Director Nominations from Jorgl Activist Group are Invalid : vimarsana.com

AIM ImmunoTech Announces that Recently Received Director Nominations from Jorgl Activist Group are Invalid

GlobeNewswire

July 18, 2022



Files Complaint in Federal Court to Compel Activist Group to Reveal True Intentions – Including a Potential Hostile Takeover of the Company – and Prevent Group from Continued Violations of Federal Securities Laws and...

Related Keywords

Florida , United States , Marion County , Netherlands , Ocala Division , Argentina , Ocala , American , Jenene Thomas , Robert Chioini , Ted Kellner , Michael Rice , Dan Zacchei Joe Germani , Franz Tudor , Todd Deutsch , Thomask Equels , Company On Twitter , Linkedin , Early Access Program , Us District Court , Omissions In Violation Of Company Bylaws , Company Annual Report On Form , American Association For Cancer Research Annual Meeting , Walter Lautz The Jorgl Activist Group , Facebook , Jorgl Activist Group , Company Board Without Payinga Premium , Company Board Of Directors , Immunotech Inc , A Potential Hostile Takeover Of The Company , Exchange Commission , Company Board , Stockholders To Prevent Activist Group , Netherlands At Erasmus Medical Center , Tech Announces , Recently Received Director Nominations , Federal Court , Compel Activist Group , Reveal True Intentions , Potential Hostile Takeover , Prevent Group , Continued Violations , Federal Securities Laws , Highlights Certain Activist Group Member History , Serious Unlawful Conduct , Unanimously Rejected Nomination Notice Due , False Statements , Best Interests , All Stockholders , Prevent Activist Group , Gaining Control , Board Without Paying , Take Any Action , Jonathan Jorgl , Jorgl Notice , Middle District , Walter Lautz , Executive Vice Chairman , Activist Group , Rockwell Medical , Lifesci Advisors , Healthcare Conference , Independent Investigators , American Association , Cancer Research Annual , Erasmus Medical Center , Tech Inc , Annual Report , Initial Statements , Beneficial Ownership ,